Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
LT-NS001, is an NSAID pro-drug for the treatment of chronic inflammatory conditions, such as osteoarthritis. Multiple phase I trials demonstrated its safety and proof of concept. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Jun 2006 - 952 pages - $2,495
Aug 2011 - 7 pages - $75
Aug 2011 - 7 pages - $75
Nov 2010 - 142 pages - $1,495
Nov 2011 - 7 pages - $75
Sep 2007 - 18 pages - $1,695
Jan 2009 - 14 pages - $1,695
Dec 2009 - 10 pages - $1,695
Jan 2011 - 42 pages - $500
Apr 2010 - 510 pages - $2,695
Your selection
Browse By
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us